About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Texas | 857 Studies

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 857 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 481-500 of 857 trials

CompletedTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerPhase I trial to study the effectiveness of trastuzumab plus R115777 in treating patients who have advanced or metastatic cancer.NCT00005842·Fort Sam Houston, Texas and 1 other Active not recruitingMultiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate CancerThis phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate…NCT03697148·Phoenix, Arizona and 43 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingPSMA PET Combined With MRI for the Detection of PCaThis is an open label, longitudinal Phase 3 study of prostate specific membrane antigen (PSMA) positron emission tomography (PET) combined with magnetic resonance imaging (MRI)…NCT07052214·Los Angeles, California and 17 others

RecruitingREGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell CarcinomaThis study is researching a new drug called REGN15505 when used alone or in combination with cemiplimab or in combination with REGN4336 in adult patients with mCRPC and ccRCC.NCT07594106·Goodyear, Arizona and 4 others

Active not recruitingStudy of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCThis is a Phase 3, multi-center, randomized, open-label, controlled study designed to evaluate the safety and efficacy of cabozantinib given in combination with atezolizumab…NCT04446117·Tucson, Arizona and 279 others

Active not recruitingPivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate CancerA prospective, multi-center, single-arm study, planned in 150 patients.NCT02766543·Los Angeles, California and 13 others

Active not recruitingStudy of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate CancerThis is a multicenter, single-arm, two-stage open-label phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate cancer…NCT05502315·La Jolla, California and 3 others

Active not recruitingA Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are DescribedThe purpose of this study is to find out in the real-world setting, if darolutamide is safe and effective for patients diagnosed with prostate cancer that has not spread to other…NCT04122976·Homewood, Alabama and 39 others

CompletedA Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate CancerThis aim of this study is to determine the safety and tolerability of elesclomol sodium at escalating doses (ultimately identifying the maximum tolerated dose) when combined with…NCT00808418·Fountain Valley, California and 4 others

CompletedAdaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking MenObjectives: The primary objective of this project is to develop and evaluate a Spanish-language slide set for administration in group settings, adapted from the content of the…NCT01447186·Houston, Texas

CompletedStudy to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to assess the safety, tolerability and preliminary efficacy of CC-94676 in men with progressive metastatic castration resistant prostate cancer.NCT04428788·Stanford, California and 18 others

CompletedINCB106385 Alone or in Combination With Immunotherapy in Advanced Solid TumorsThis is a multicenter, open-label, dose-escalation/dose-expansion Phase 1 clinical study to investigate the safety, tolerability, PK profile, pharmacodynamics, and preliminary…NCT04580485·West Hollywood, California and 26 others

Enrolling by invitationMediterranean Diet Intervention Among Men at LBJ Hospital With Prostate CancerThis study, we will build upon our prior work and test the feasibility of a Mediterranean diet intervention for medically underserved men with prostate cancer seen at LBJ…NCT06935097·Houston, Texas

CompletedEnzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate CancerThe study is being done to find out whether combining two FDA approved drugs along with radiation therapy for the treatment of high risk localized prostate cancer is safe and well…NCT02064582·Dallas, Texas

CompletedA Study of Degarelix in Patients With Prostate CancerThe purpose of this study was to see if giving Degarelix every month for 7 months then stop treatment for 7 months (intermittent therapy) would show a reduction of negative…NCT00928434·Alexander City, Alabama and 58 others

CompletedStudy of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate CancerRandomized, double-blind, placebo controlled, dose finding Phase 2 study comparing oral daily dosing of VERU-944 after a week of loading (daily dosing) with placebo to ameliorate…NCT03646162·Glendale, Arizona and 23 others

Active not recruitingA Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate CancerThe main purpose of this study is to determine if the addition of apalutamide to radiotherapy (RT) plus luteinizing hormone-releasing hormone agonist (LHRHa) delays metastatic…NCT04557059·Tucson, Arizona and 140 others

TerminatedDocetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer PatientsThe primary objective of this study is to compare the duration of survival between patients receiving docetaxel in combination with the GVAX® vaccine for prostate cancer versus…NCT00133224·Anchorage, Alaska and 114 others

CompletedA Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)This is a randomized, double-blind, placebo-controlled, multinational Phase 2 study to evaluate and compare oral AT-101 in combination with docetaxel and prednisone versus…NCT00571675·Colorado Springs, Colorado and 34 others

CompletedPersonal Patient Profile Prostate (P4) Randomized, Multisite TrialThe purpose of this study is to determine whether or not participation in an experimental program called the "P4 program" is useful to men who are faced with choices about…NCT00692653·Augusta, Georgia and 5 others

PreviousPage 25 of 43Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma